Does untreated hearing loss exacerbate cognitive decline? Dr Jennifer Deal and her colleagues
at Johns Hopkins have been researching aspects of hearing loss and cognition, and are currently
engaged in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study, a randomized
trial to determine efficacy of hearing intervention on reducing cognitive decline in older adults.
Eargo’s proprietary algorithm “identifies the user’s surroundings and instantly modifies the hearing device’s settings to ensure optimal benefit, without requiring manual input from the wearer.”
Read More
A month-by-month list of some of the year’s most important news items from ‘The Hearing Review.’
Read More
GN Hearing has acquired a controlling interest in online hearing care provider Lively, obtaining a 91% ownership stake in the company for $94.8 million.
Read More
Netherlands-based audio software company Absolute Audio Labs (AAL) announced that the company has been awarded a CES Innovation Award for its PYOUR Eccellenza AI premium+. This series of hearing aids consists of a Hearable and a RIC reference design.
Read More
The $1.9 trillion Build Back Better Act was passed by the US House of Representatives on Friday, November 19, and is now with the Senate for what is sure to be a bumpy ride. The bill includes coverage of hearing aids once every 5 years for people with severe to profound hearing loss, as well as funding for universal preschool, expanded Child Tax Credits, several health and pandemic-related initiatives, renewable energy credits, and more.
Read More
Intricon, an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable, and body-worn medical devices, announced financial results for its third quarter ended September 30, 2021.
Read More
The “Build Back Better” legislation being considered by Congress would provide Medicare coverage of hearing aids and services once per ear every 5 years, and now includes audiologists, hearing aid specialists, and other qualified healthcare providers.
Read More
Signia announced its Insio Charge&Go AX and Pure Charge&Go T AX, are now available to US Department of Veterans Affairs (VA) audiologists treating military veterans, as well as audiologists within the US Department of Defense (DoD), for active military, and Indian Health Service (IHS).
Read More
Getting answers to important questions about managed care and how it fits in your unique practice is vital. Here are some basic business calculations and metrics for understanding how a managed care plan might benefit, or not benefit, your practice.
Read More
Starkey announced that its newest line of hearing aids are now compatible with iPhone and iPad, making it possible for those with hearing loss to have hands-free conversations. With the release of iOS 15 and iPad OS 15 earlier this year, Apple has added support for bidirectional hearing aids, such as Starkey’s Evolv AI hearing aids which include new bidirectional streaming technology.
Read More
As patient-centric care gains steam in both general medicine and hearing health—while being juxtaposed by new OTC and DIY hearing solutions—a renewed focus on follow-up services is crucial. This special report looks at follow-up AR protocols and perspectives, and includes perspectives from Nancy Tye-Murray, Brian Taylor, Cherilee Rutherford, Ron Leavitt, Susanna Løve, Dave Blanchard, and more.
Read More
Based on his years working in the hearing healthcare industry, Brandon Sawalich, Starkey CEO, dispels “5 Leadership Myths” in an article published on the “Forbes” website.
Read More
Weave, an all-in-one customer communication platform for small business, and Sycle, a provider of audiology practice management software, announced the launch of an integration to bring more products and services direct to practices in a simple, streamlined solution.
Read More
Summative Usability Validation has been completed, which helps demonstrate that users can “safely and correctly use the Intricon self-fitting technology,” and the clinical trial of the software can move forward.
Read More